Showing results (131-140 of 616) with videos related to
Sort By:
Pageof 62
Pharmacology, Biochemistry, and Behavior|December 1, 1986
Mouth versus deep airways absorption of nicotine in cigarette smokersG B Gori, N L Benowitz, C J LynchAnnals of Neurology|February 1, 1986
Status epilepticus: divergence of sympathetic activity and cardiovascular responseN L Benowitz, R P Simon, J R CopelandThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Pharmacodynamic model of tolerance: application to nicotineH C Porchet, N L Benowitz, L B SheinerThe Cochrane Database of Systematic Reviews|July 22, 2004
Clonidine for smoking cessationS G Gourlay, L F Stead, N L BenowitzDrug and Alcohol Dependence|May 24, 2000
Clinical pharmacology of oral cotinineS Zevin, P Jacob, P Geppetti, et al.Preventive Medicine|March 1, 1995
Is serum cotinine a better measure of cigarette smoking than self-report?E J Pérez-Stable, N L Benowitz, G MarínThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotineN L Benowitz, P Jacob, I Fong, et al.Clinical Pharmacology and Therapeutics|March 1, 1991
Stable isotope studies of nicotine kinetics and bioavailabilityN L Benowitz, P Jacob, C Denaro, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2010
Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illnessJill M Williams, Kunal K Gandhi, Neal L BenowitzClinical Pharmacology and Therapeutics|July 1, 1994
Divergent tolerance to metabolic and cardiovascular effects of nicotine in smokers with low and high levels of cigarette consumptionL Arcavi, P Jacob, M Hellerstein, et al.Pageof 62